Latest Capital Management News

Metcash Limited reported steady FY26 half-year results with modest revenue growth, strong cash flow, and resilience amid tobacco sales decline. The company’s digital B2B marketplace 'Sorted' is rapidly expanding, underpinning future growth prospects.

Whitefield Industrials Limited has announced a fully franked ordinary dividend of AUD 0.105 per share for the half-year ending September 2025, alongside shareholder reinvestment options.

Alligator Energy has sold its Northern Territory uranium assets to DevEx Resources for $7.5 million, streamlining its portfolio to concentrate on South Australian projects like Samphire. This move injects liquidity and reduces ongoing costs, positioning the company for accelerated development.

Rox Resources secures ASX waiver allowing a discounted Share Purchase Plan without shareholder approval, enabling eligible investors to buy shares at $0.35 each. This move streamlines capital raising while limiting dilution to around 2.5%.

Conico Ltd has appointed a new external auditor and secured shareholder approval for a significant 1-for-8 share consolidation at its 2025 Annual General Meeting.

Papyrus Australia has marked significant progress at its Adelaide R&D facility while its sustainable fibre board gains international recognition, setting the stage for expanded global partnerships.

BTC Health has broadened its medical product portfolio through strategic acquisitions and organic growth, reporting strong early revenue gains while cautiously navigating the uncertain timing of ECMO system adoption.

Ionic Rare Earths Limited secured shareholder approval on all resolutions at its 2025 Annual General Meeting, including director election, share consolidation, and capital raising measures.

BTC Health has raised $2 million through a share placement priced at a slight premium, with director Martin Kahanovitz participating and a new South African investor joining the register.

Emeco Holdings has refinanced its long-term debt with a new A$355 million facility, extending maturity and improving terms to support future growth.

CD Private Equity Fund III reported a $3.02 million net loss for the half-year ending September 2025, driven largely by foreign currency translation losses, yet maintained a 10 cent per unit distribution supported by portfolio realisations and cash management.

CD Private Equity Fund II reported a reduced net loss of $2.43 million for the half-year to September 2025, supported by $9.45 million in distributions from portfolio realisations. Despite foreign exchange headwinds, the Fund maintains a diversified portfolio and a positive long-term return track record.